Skip navigation

New Trial Designs and Innovative Approaches to Grow Scientific Knowledge and Tailor Treatments to More Patients

October 29-30, 2019
  • Philadelphia, PA

Clinical trials are one of the most pressing pain points in drug development with over 86% of trials failing. One of the largest contributors to this challenge is the difficulty in recruiting and retaining patients particularly those with rare conditions. Fortunately there’s hope by way of new trial formats and protocols that allow life sciences companies to broaden their patient pools by focusing on mutation categories in basket trials and allowing patients to try more drugs by way of umbrella trials.

Whether you call it basket & umbrella, platform, master trial, or adaptive it’s critical that implementation is seamless and efficient.

CBI’s Basket & Umbrella Trials for Clinical Oncology returns as the leading event to help you ensure clinical success by adopting new trial formats, learning to operationalize trials, mastering legal hurdles, gaining strategies for patient recruitment, and designing cutting edge trial protocols.

Key Takeaways:

  • Efficiently operationalize basket and umbrella trials
  • Ensure your team is prepared and trained for
    emerging clinical formats
  • Overcome the protocol complexities of large scale
    umbrella and basket trials
  • Manage multi manufacturer trial contract; protecting legal commitments, proprietary data, and a competitive market place
  • Master biomarker screening by learning the insider secrets of patient trial assignments
  • Mitigate costs and excessive labor in basket and umbrella trials

Basket & Umbrella Trials for Clinical Oncology

New Trial Designs and Innovative Approaches to Grow Scientific Knowledge and Tailor Treatments to More Patients

Clinical trials are one of the most pressing pain points in drug development with over 86% of trials failing. One of the largest contributors to this challenge is the difficulty in recruiting and retaining patients particularly those with rare conditions. Fortunately there’s hope by way of new trial formats and protocols that allow life sciences companies to broaden their patient pools by focusing on mutation categories in basket trials and allowing patients to try more drugs by way of umbrella trials.

Whether you call it basket & umbrella, platform, master trial, or adaptive it’s critical that implementation is seamless and efficient.

CBI’s Basket & Umbrella Trials for Clinical Oncology returns as the leading event to help you ensure clinical success by adopting new trial formats, learning to operationalize trials, mastering legal hurdles, gaining strategies for patient recruitment, and designing cutting edge trial protocols.

Key Takeaways:

  • Efficiently operationalize basket and umbrella trials
  • Ensure your team is prepared and trained for
    emerging clinical formats
  • Overcome the protocol complexities of large scale
    umbrella and basket trials
  • Manage multi manufacturer trial contract; protecting legal commitments, proprietary data, and a competitive market place
  • Master biomarker screening by learning the insider secrets of patient trial assignments
  • Mitigate costs and excessive labor in basket and umbrella trials